This is what the virus uses to enter cells and cause an infection.
AstraZeneca, a British-Swedish company, said earlier in March that its vaccine was 76 percent effective in preventing symptomatic coronavirus infections in a trial held in the United States, and that studies did not indicate higher risks of clotting.
In most cases, the reactions were mild and resolved within 2 days.
The Sinovac vaccine uses more traditional vaccine technology, relying on inactivated virus particles to produce an immune response.
The reasons for this are unclear, and more research needs to be done to provide a better understanding.
These recipients may also get a booster — a fourth dose — at least six months after the third shot, according to.
Notícias ao Minuto in Portuguese.
.